ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB2287

    D-dimer Diagnostics: An International Assessment of the Quality of Laboratory Testing

    C. Elbaz1, P. Meijer2, M. van Essen-Hollestelle2, Z. Liederman1, R. Selby1,3

  • Abstract Number: PB2261

    D-Dimer is Useful in the Assessment of Suspected Recurrent Venous Thromboembolism in Patients on Rivaroxaban or Apixaban

    H.L.A. Yuen1,2, E. Malan1, J. Clifford1, A. Bennett1, A. So1, P. Leung1, S. Chunilal1,2

  • Abstract Number: PB2277

    D-Dimer Plasma Levels and the Anatomical Extension of Acute Symptomatic Deep Vein Thrombosis of the Lower Limbs

    B. Cosmi1, C. Legnani2, M. Cini2, G. Guazzaloca1, G. Rodorigo1, M. Sartori1, G. Palareti2

  • Abstract Number: PB2516

    D-Dimer Variability in the Postpartum Period

    T. Malinova, D. Stambolieva, S. Ortakovska

  • Abstract Number: PB0993

    Data Mining: An Innovative Approach to Optimise Post-Hoc Analyses of Large Trial Data Sets into Clinically Relevant Results

    P. Chowdary1, S. Benchikh El Fegoun2, M.S. Geybels3, A. Tiede4

  • Abstract Number: OC 03.3

    Deciphering the Ets-1/2-mediated Transcriptional Regulation of F8 Gene Identifies a Minimal F8 Promoter for Hemophilia A Gene Therapy

    R. Famà1, E. Borroni1, S. Merlin1, S. Pignani1, C. Airoldi2, A. Cucci1, V. Bruscaggin1, S. Scardellato1, M. Pinotti3, G.E. Walker1, A. Follenzi1

  • Abstract Number: PB0487

    Deciphering the Protein Secretome of Leukocyte-platelet Rich Fibrin

    L. Hermida Nogueira1, M.N. Barrachina1, L.A. Morán1, S. Bravo2, P. Diz3, J. Blanco3, Á. García1

  • Abstract Number: PB2199

    Decreased Expression of Annexin A2 Is Associated with Reduced Cell Surface Fibrinolysis and Venous Thromboembolism

    K. Hajjar, H. Fassel, H. Chen, M. Ruisi, N. Kumar, M. De Sancho

  • Abstract Number: PB0846

    Decreased Platelet Surface Phosphatidylserine Predicts Increased Bleeding in Patients with Severe Factor VIII Deficiency

    A.L. Frelinger III1,2, S.E. Croteau2,3, A.J. Gerrits1,2, A.D. Michelson1,2

  • Abstract Number: PB2147

    Decreased Thrombin Generation Potential in Lymphoma Patients Is Associated with Increased D-dimer, CRP, vWF and TNF-α. Interrelationship between Thrombogenesis and Inflammation

    F. Siddiqui1, E. Bontekoe1, D. Antic2, D. Hoppensteadt1, G. Gerotziafas3, J. Fareed1

  • Abstract Number: PB0748

    Deep Mutational Scanning and High-Throughput Kinetics to Quantitatively Assess Plasminogen Activator Inhibitor-1 Variants

    L.M. Haynes1, Z.M. Huttinger1, D. Ginsburg1,2

  • Abstract Number: PB0215

    Deep Vein Thrombosis and Coagulation Factor Deficiency: A Paradoxical Association

    Y. Cherif, M. Mrouki, R. Ghariani, S. Derbel, F. Ben Dahmen, M. Abdallah

  • Abstract Number: PB2238

    Deep Vein Thrombosis Associated with Protein S Deficiency

    P. Romadhon, M. Savitri, P. Niken, U. Bintoro, M. Sedana, A. Ashariati

  • Abstract Number: PB2144

    Deep Venous Thrombosis and Intraductal Papillary and Mucinous Tumor of the Pancreas: about 3 Cases

    Y. Cherif1, R. Ghariani2, M. Mrouki1, S. Derbal1, F. Ben Dahmen1, M. Abdallah1

  • Abstract Number: PB2304

    Deep Venous Thrombosis with Atypical Location: About 22 Cases

    S. Derbal, Y. Cherif, F. Ben Dahmen, M. Abdallah

  • Abstract Number: PB1488

    Defective Endocytosis of Albumin, Fibrinogen and IgG in Platelets with RUNX1 Haplodeficiency

    F. Del Carpio-Cano1, G. Mao2, L. Goldfinger3, J. Wurtzel3, A.K. Rao1

  • Abstract Number: PB1502

    Defective RAB31-mediated Endosomal Trafficking in RUNX1 Haplodeficiency

    G. Jalagadugula1, G. Mao1, L. Goldfinger2, J. Wurtzel2, M. Lambert3, A.K. Rao1

  • Abstract Number: PB1996

    Defibrotide Prevents Sepsis Induced Endothelial Cell Activation

    M. Palomo1, S. Fernandez2, P. Molina3, J. Aibar2, J. Nicolas2, P. Castro2, M. Diaz-Ricart3

  • Abstract Number: PB0473

    Defining Acetylsalicylic Acid Responsiveness: Understanding the Relation between Thromboxane B2 Inhibition and Aggregation Induced by Arachidonic Acid

    K. Bliden1, U. Tantry1, G. Ens2, W. Messbarger2, R. Chaudhary3, P. Gurbel4

  • Abstract Number: PB1848

    Defining the Effects of Storage Lesion on Platelet Autophagic Activity

    S. Fauteux-Daniel1,2, E. Audoux2, J. Fagan1,2, H. Hamzeh-Cognasse2, M.-A. Eyraud1,2, C.-A. Arthaud1,2, O. Garraud2,3, A. Bernard1, P. Verhoeven2,4, S. Laradi1,2, F. Cognasse1,2

  • Abstract Number: PB1582

    Degradation of High Molecular Weight von Willebrand Factor Multimers during Extracorporeal Membrane Oxygenation-Treatment

    M.-S. Kim1, C.-J. Park1, S. Jang1, Y.-U. Cho1, S.-B. Hong2

  • Abstract Number: PB0278

    Delay in Time to Hip Fracture Repair Surgery among Elderly Patients Treated with Anti Platelet Therapy

    A. Lubetsky1,2, A. Seltser2,3

  • Abstract Number: PB2402

    Demographics and Clinical Outcomes of Older Adults Treated for Acute Venous Thromboembolism

    R. Chaudhary1, D.T. Vlazny2, A.I. Casanegra2, D.E. Houghton2, D.A. Froehling2, L.G. Peterson2, D.O. Hodge3, R.D. McBane II2, W.E. Wysokinski2

  • Abstract Number: PB2400

    Demographics and Clinical Outcomes of Patients Younger than 40 Years Treated for Acute Venous Thromboembolism

    D.T. Vlazny1, W. Wysokinski1, D.E. Houghton1, D.O. Hodge2, D.A. Froehling1, L.G. Peterson1, A.I. Casanegra1

  • Abstract Number: PB1992

    Design and Characterization of Novel Activated Protein C (APC) Variants for the Proteolysis of Cytotoxic Extracellular Histone H3

    J. Huckriede, D. Beurskens, K. Wichapong, K. Wildhagen, T. Hackeng, C. Reutelingsperger, G. Nicoleas

  • Abstract Number: PB1157

    Design of a Novel Factor IX Albumin Fusion Protein with Enhanced Coagulant Activity and Pharmacokinetic Profile

    S. Lombardi1, J. Nilsen2,3, K. Hovden Aaen2,3, M. Ferrarese1, M. Pinotti1, M. Bern2,3, D.C. Roopenian4, I. Sandlie2,5, J.T. Andersen2,3, A. Branchini1

  • Abstract Number: PB0259

    Design of Polyphosphate Inhibitors that Reduce Thrombosis without Increased Bleeding

    C.C. La1,2, S.A. Smith3, M.D.G. Jaraquemada-Peláez1,2, S. Abbina1,4, L.A. Creagh5, C.A. Haynes5, J.H. Morrissey3, J.N. Kizhakkedathu1,2,4

  • Abstract Number: PB1330

    Desmopressin for Procedures or Radiological Interventions (DRIVE): Participant Characteristics in a Placebo-Controlled Double-Blind, Randomised Feasibility Trial of Desmopressin in Thrombocytopenic Critically Ill Patients Prior to Procedures

    M. Desborough1, E. Laing2, A. Griffiths3, A. Mora2, R. Hodge2, S. Martin2, A. Shah4, P. Hutton5, T. Parke6, M. Wise7, M. Morgan7, S. McKechnie5, S. Stanworth4,8, DRIVE Trial Investigators

  • Abstract Number: PB1390

    Desmopressin for Reversal of Antiplatelet Drugs in Stroke due to Haemorrhage (DASH): Interim Report on Recruitment from a Phase II Double Blind Randomised Controlled Trial

    M. Desborough1, R. Al-Shahi Salman2, S. Stanworth3,4, D. Havard5, P.M. Brennan2, R. Dineen5, T. Coats6, P. Johnson7, T. Hepburn8, P. Bath5, N. Sprigg5, DASH Trial Investigators

  • Abstract Number: PB1579

    Desmopressin in Patients with Type 2B von Willebrand Disease: Differential Impact on VWF and Platelet Function

    A. Dupont1,2, A. Rauch1,2, C. Paris1,2, F. Lassalle1,2, A. Hochart1,2, B. Wibaut1,2, A. Bauters1,2, J. Goudemand1,2, C. Zawadzki1,2, E. Jeanpierre1,2, S. Susen1,2

  • Abstract Number: PB1133

    Desmopressin Response and Clinical Outcome in Bleeding Disorders: A 30 Year Retrospective Analysis

    M.R. Peralta1, B. Gration1, A. Agapidou2, C.D. Garcia1, T.T. Yee1, A. Riddell1, K. Gomez1, Z. Hanif1, A. Drebes1, C. Hamid1, P. Morjaria1, E. Aradom1, D. Pollard1, P. Chowdary1

  • Abstract Number: PB0893

    Detectability and Clinical Significance of Calcium Exchange and 25 (OH) D in the Development of Osteoporosis in Patients with Hemophilia

    N. Akhrarova, A. Makhmudova, L. Ashurova, O. Madasheva

  • Abstract Number: PB0246

    Detecting Oral Kallikrein-Targeting Therapy through Triggered Contact Activation: A Phase I Study

    C. Clark1, Z.L.M. Hofman1,2, C.E. Hack2, S. de Maat1, C. Maas1

  • Abstract Number: PB0344

    Detection and Quantification of F8 Inv1 and Inv22 Inversions Using Digital Droplet PCR and Mile-post Assays

    E. Manderstedt1, C. Lind-Halldén1, A. Lidén1, R. Ljung2, J. Astermark2, C. Halldén1

  • Abstract Number: PB1393

    Detection of Clopidogrel Resistance: Comparison of Light Transmission Aggregometry and INNOVANCE® PFA P2Y Cartridge and Correlation with CYP2C19 Variants

    L. Heireman, K. Devreese

  • Abstract Number: PB2292

    Detection of MicroRNA-126 as a Plasma Biomarker for Diagnosis of DVT

    X. Bai, J. Su, Y. Zhao, W. Zhang, C. Ruan

  • Abstract Number: PB1423

    Detection of Pathogenic Anti-platelet Factor 4 Antibodies by Impedance Spectroscopy

    N.Z. Khan1, D. Frense2, A. Lindenbauer1, T.-H. Nguyen1

  • Abstract Number: PB0829

    Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations

    M.F. Testa1, S. Lombardi1, M. Ferrarese1, M. Pinotti1, G. Castaman2, P. Radossi3, D. Belvini4, F. Bernardi1, A. Branchini1

  • Abstract Number: PB2014

    Determinants of Neutrophil Extracellular Trap Formation in the General Population: Based on the Rotterdam Study Cohort

    S.J. Donkel1, F.J. Wolters2, M.A. Ikram2, M.P.M. de Maat1

  • Abstract Number: PB0676

    Determination of Serotonin Concentration in Single Human Platelets by Single-entity Electrochemistry

    J. Lee1, Y. Kang1, J. Chang2, J. Song3, B.-K. Kim1

  • Abstract Number: PB1445

    Determination of the Genotype of von Willebrand Disease Type 3

    D. Provazníková1, F. Mareček1, F. Oyen2, V. Geierová3, J. Loužil3, A. Radovská1, M. Šimoníková1, R. Schneppenheim2, P. Salaj3, I. Hrachovinová1

  • Abstract Number: PB2290

    Determining Predictive Factors of Venous Thromboembolism Using Design of Experiments

    G.Y. Ottaiano1, J.M. Annichino-Bizzacchi2, R. Maciel-Filho3, T.D. Martins1

  • Abstract Number: PB1149

    Determining the Approximate Factor VIII Level Equivalency of Patients with Severe Hemophilia A on Emicizumab Using Global Hemostasis Assays

    H. Kizilocak1, E. Marquez-Casas1, J. Malvar1, R. Carmona1, G. Young1,2

  • Abstract Number: PB1152

    Determining the Optimal Method for FVIII:C and Anti-FVIII Quantification in a Patient Treated with Adynovi® who Developed Anti-FVIII during Treatment

    L. Heireman, K. Devreese

  • Abstract Number: PB2169

    Developing an ex vivo Method to Study Thrombosis in Cancer Patients: Cancer-associated Thrombosis-on-a-Chip

    A.M.R. Rondon1, E.H. Laghmani1, W. Stam2, V. van Duinen2, K. Queiroz3, P. Vulto3, A.J. van Zonneveld2, H. Versteeg1

  • Abstract Number: PB2299

    Developing Fluidic Models that Replicate Cephalic Arch Geometry and Flow Conditions of Dialysis Patients to Understand and Predict Access Thrombosis

    A. Moya Rodriguez1, C. Bernstein2, B. Xie2, M. Hammes3, A. Basu2

  • Abstract Number: PB0122

    Developing of a New Animal Artery Model of Atherothrombotic Stenosis using Perivascular Monopolar High-Frequency Electrical Current-Mediated Endothelial Injury Followed by a Cholesterol-Rich Diet Injury and Finally Perivascular Severe Cold Injury using Liquid Nitrogen

    H. Mehrad1, M. Farhoudi2

  • Abstract Number: PB2496

    Development and External Validation of a Risk Assessment Model for First Venous Thromboembolism in Women Starting Combined Oral Contraceptives

    D.K. Khialani1, S. Arcudi2, S. Cannegieter1, A. van Hylckama Vlieg1

  • Abstract Number: PB0350

    Development and Performance Characterization of an Automated Chromogenic Assay for Human Factor IX Activity

    N. Ramamurthy, S. Duffin, C. Kucharski, Z. Vandertuin, S. Kaushik, M. Morris

  • Abstract Number: PB1871

    Development and Validation of a Prediction Model (AHC) for Early Identification of Refractory Thrombotic Thrombocytopenic Purpura Using Nationally Representative Data

    Q.-S. Huang1,2,3, R.-Y. Gui1,2,3, Y. Liu4, H. Liu5, M.-Y. Fang6, L.-H. Yang7, J.-Y. Zhang8, Y.-F. Cheng9, M. Jiang10, M. Mao11, L.-R. Wang12, Z. Wang13, H.-B. Zhou14, H. Lan15, Z.-X. Jiang16, X.-L. Shen17, L. Zhang18, S.-J. Fan19, X.-J. Huang1,2,3, X.-H. Zhang1,2,3

  • Abstract Number: PB0119

    Development of a Clinical Cohort of HIV-infected Patients with Peripheral Vascular Disease

    E. Mayne1, A.T.O. Abdool-Carim2, T.T. Monareng2, N. Funderburg3, W.S. Stevens4,5, M. Lederman6, S. Louw5,7

  • Abstract Number: PB0678

    Development of a Flow Cytometry-based Assay for the Detection of ITP Autoantibodies

    M. Neves1,2, A. Arad3, Y. Wang1, G. Zhu1, R. Galant1, M. Thompson4, H. Ni1,2

  • Abstract Number: PB0527

    Development of a Logistic Regression Model for Prediction of Conversion Risk from Mild Cognitive Impairment (MCI) to Alzheimer´s Disease (AD)

    G.S. Gonçalves1, M.A. Bicalho2, M.T. Cintra2, C. Moreira3, R.C. Duarte1, E. Reis3, D.R. Rios4, L.M. Dusse1, K.B. Borges1, M.D.G. Carvalho1

  • Abstract Number: PB0468

    Development of a Microfluidic Pillar Device to Study Hemostasis in vitro

    H.H.S. Lakshmanan1, A. Pore2, J.J. Shatzel1, P. Cristina1, P. Jurney3, J. Maddala4, S.A. Vanapalli2, O.J.T. McCarty1

  • Abstract Number: PB1966

    Development of a Novel Mouse Model of Abdominal Aortic Aneurysm with Intraluminal Thrombus

    K. Yahiaoui1, C. Herbet1, R. Martos1, H. Lebas1, B. Ho Tin Noe1, W. Bergemeier2, P. Conley3, E. Camerer4, M.C. Bouton1, Y. Boulaftali1

  • Abstract Number: PB0497

    Development of an Accessible Open Source Code in Python for High-Resolution Melting Data Analysis from Patients Diagnosed with Hemophilia A in Bogotá, Colombia

    J. Lago1, D.L. Navas1, P.A. Lago2, M.C. Gamboa3, D.C. Polanía1, H. Groot1

  • Abstract Number: PB2425

    Development of Cyclic Peptide Inhibitors of Coagulation Factor XIa for Safer Anticoagulation

    V. Carle1, Y.T. Wu1, R. Mukherjee1, X.-D. Kong1, J. Goto2, B. Stegmayr2, C. Heinis1

  • Abstract Number: PB2100

    Development of Predictive Score for Venous Thromboembolism in Hematologic Malignancies

    A. López Sacerio1, S. Rendón Peralta2, E. Barreto Fiu3, N. Alvarez Basulto4, M. Acosta Alvarez1

  • Abstract Number: PB2534

    Deviations in Red Blood Cell Gas Transport Function in Pregnant State

    E. Iastrebova1,2, E. Kolegina1, V. Maltsev1,2

  • Abstract Number: PB0030

    Diabetes Mellitus and Risk of Intracranial Atherosclerosis: A Meta-Analysis Using Real-World Evidence

    S. Hussain1, A.K. Najmi2

  • Abstract Number: PB2011

    Diabetes Mellitus Increases Thrombin and Activated Protein C Effects on Mast Cell and Macrophages

    L. Gorbacheva1,2, E. Kiseleva3, I. Goliako1

  • Abstract Number: PB0507

    Diagnosing and Categorizing Acquired Fibrinolysis Activity with Global Hemostatic Assays

    G. Mohan, S. Shastry, P.A. Prethika, D. Kandasamy

  • Abstract Number: PB2267

    Diagnosing Deep Vein Thrombosis in Patients with Suspected Symptoms and a Concurrent Malignancy: An Individual Participant Data Meta-Analysis

    T. Takada1, S. van Doorn1, S. Parpia2, K. de Wit3, D. R. Anderson4, S. M. Stevens5,6, S. C. Woller5,6, A.J. ten Cate-Hoek7, J. L. Elf8, R. A. Kraaijenhagen9, R. E.G. Schutgens10, P. S. Wells11, C. Kearon3, K. G. M. Moons1, G.-J. Geersing1

  • Abstract Number: PB0786

    Diagnosis and Management of Acquired Von Willebrand Disease in Two Italian Centers

    A. Ferretti1, E. Baldacci1, M. Basso2, R. Abbruzzese1, M.L. De Luca1, F. Barone1, R. Bochicchio1, A. Chistolini1, M.G. Mazzucconi1, E. De Candia3, C. Santoro1

  • Abstract Number: PB0824

    Diagnosis and Management of Acute Hemarthrosis and Haemophilic Arthropathy in Spain Using Unified Clinical and Ultrasound Criteria: Preliminary Results

    A. Chimeno Hernandez1, S. Pérez-Alenda2,3, J.J. Carrasco2,4, M. Aguilar3,5, S. Haya3, A.R. Cid3, J.E. Megías6, S. Bonanad3, F. Querol2,3

  • Abstract Number: PB1590

    Diagnosis and Management of von Willebrand Disease in a Portuguese Reference Center of Congenital Coagulopathies

    C. Catarino Oliveira1, F. Rodrigues1, A. Pereira1, S. Campaniço1, M. Teodoro1, C. Silva Pinto2, P. Martinho2, T. Fidalgo2

  • Abstract Number: PB0362

    Diagnosis and Treatment of Obstetrics Disseminated Intravascular Coagulation in Resource Limited Settings

    H. Okoye1, T. Nwagha1, E. Ugwu2, I. Menuba2, A. Duru1, A. Ugwu1, I. Ezebialu3, S. Eze4, A. Ugwu5

  • Abstract Number: PB1437

    Diagnosis of Inherited Platelet Disorders on a Blood Smear: The One-Year Experience of a Reference Laboratory

    C. Zaninetti1,2, M. Baschin2, C. Freyer2, A. Greinacher2

  • Abstract Number: PB1522

    Diagnosis of von Willebrand Disease in Algeria Laboratory and Clinical phenotype: Single Center Experience

    D. Benlaldj1,2, M.A. Mouedene1

  • Abstract Number: PB1435

    Diagnostic Approach to Inherited Thrombocytopenias in a Low-Income Setting

    A.C. Glembotsky1,2, N.P. Goette1, C.P. Marin Oyarzún1,2, C. Baroni Pietto1,2, D. Ayala1,2, D. Altuna3, M.E. Arrieta4, N. Basak5, S. Bonacorso6, A. Brodsky6, H. Donato7, J.D. Korin8, P. Lagrotta9, F. Negro10, C. Ponzinibbio11, E. Veber12, A. Savoia13,14, A. Pecci15, R.F. Marta1,2, P.G. Heller1,2

  • Abstract Number: PB0671

    Diagnostic Performances Evaluation of LIAPHEN Free Protein S on CS-2500

    C. Dunois1, P. Gueret2, R. Parage2, A. Pontis2, F. Nedelec2, I. Gouin2, J. Amiral1

  • Abstract Number: PB1589

    Diagnostic Performances Evaluation of LIAPHEN vWF: Ag on CS-2500

    C. Dunois1, P. Gueret2, R. Parage2, A. Pontis2, F. Nedelec2, I. Gouin2, J. Amiral1

  • Abstract Number: PB1664

    Dietary Intake of Zinc Modulates Platelet Intracellular Levels and Haemostatic Parameters

    U. Sumya1, C. Whyte1, J. Beattie2, F. Thies2, N. Mutch1

  • Abstract Number: PB0330

    Difference Molecular Profiles of Type 1 and 2 Inhibitor Developed in Mild/Moderate Hemophilia A

    S. Furukawa1,2, K. Nogami1, M. Shima1,2

  • Abstract Number: PB/LB03

    Differences in Outcomes between Real-World vs Clinical Trial in Atrial Fibrillation and Chronic Kidney Disease

    W.Y. Ding1, J.M.R. Caravaca1,2, V. Roldán3, G.Y.H. Lip1,4

  • Abstract Number: PB1003

    Differences in Pharmacokinetic Evaluated by Clotting and Chromogenic Factor VIII Assays in Twelve Persons with Severe Hemophilia A on Prophylaxis with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc)

    E. Cruz, M. Pereira, M. Coutinho, R. Matos, L. Moreira, S. Morais

  • Abstract Number: PB0845

    Differences in the Prediction of the Time above Target in Hemophilia A Patients Using a Chromogenic Assay and a One-stage Assay in Model-informed Precision Dosing

    D.W. Uster1, C.D. Garcia2, A. Riddell2, E. Aradom2, M. Musarara2, C. Hamid2, C. Tait3, S. Mangles4, N. Curry5, P. Chowdary2, S.G. Wicha1

  • Abstract Number: PB2051

    Differences in Treatment and Outcomes in Recently Diagnosed Atrial Fibrillation between the Netherlands and Belgium: Results from the GARFIELD-AF Registry

    J. Seelig1,2, M.E.W. Hemels1,3, O. Xhaët4, M.C.M. Bongaerts5, A. de Wolf6, B.E. Groenemeijer7, A. Heyse8, P. Hoogslag9, J. Voet10, J.P.R. Herrman11, G. Vervoort12, W. Hermans13, B. Wollaert14, L.V.A. Boersma15,16, K. Hermans17, A. Lucassen18, K. Pieper19, F.W.A. Verheugt11, F. Cools20, H. ten Cate2,21, on behalf of the GARFIELD-AF Investigators

  • Abstract Number: PB0753

    Different Incorporation of Apha2-plasmin Inhibitor C-terminal Forms into the Fibrin Clot

    B. Baráth, É. Katona

  • Abstract Number: PB2148

    Differential Augmentation of Thrombin Generation by Andexanet Alfa in Lymphoma Patients

    F. Siddiqui1, D. Antic2, E. Bontekoe1, D. Hoppensteadt1, N. Baig1, G. Gerotziafas3, A. Tafur4, J. Fareed1

  • Abstract Number: PB1857

    Differential Diagnosis of Thrombotic Thrombocytopenic Purpura at Acute Phase by the Ratio of VWF Activity to VWF Antigen Based on Automatic Immunologic Assays

    N. Tang

  • Abstract Number: PB2062

    Differential Effect of Direct Oral Anticoagulants (DOACs) on Thrombin Generation and Clot Lysis in Patients with Non Valvular Atrial Fibrillation (AF) and Venous Thromboembolism (VTE)

    L. Dirienzo1, A. Vitulli1, C.T. Ammollo1, F. Mancazzo1, C. Dellanoce2, O. Paoletti2, S. Testa2, M. Colucci1

  • Abstract Number: PB0009

    Differential Effects of Clopidogrel with or without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Placebo-Controlled Trial in Healthy Volunteers

    L. Traby1, M. Kollars1, A. Kaider2, J.M. Siller-Matula3, H.C. Puhr1, O. Steinbrecher1, L. Eischer1, M. Wolzt4, P.A. Kyrle1, S. Eichinger1

  • Abstract Number: PB1939

    Differential Expression of CD46 in Leukocytes by Flow Cytometry: Methodological Aspects

    S. Rotondo1, C. Dos Santos2, M.F. Alberto1, A. Sánchez-Luceros1,2

  • Abstract Number: PB1970

    Differential Expression of Inflammatory Mediators in Venous Tissue and Serum Suggest Natural Killer (NK) Cell-mediated Responses in Chronic Venous Insufficiency

    U. Sachdev, L. Vodovotz, D. Barclay, J. Yin, R. Zamora, Y. Vodovotz

  • Abstract Number: PB2167

    Differential Expression of Neutrophil Activation Markers in Venous Thromboembolism Patients with and without Association to Cancer

    J. Oto1, V. Sánchez-López2, E. Arellano2, T. Elias3, L. Jara2, M.I. Asensio3, R. Otero3, P. Medina1

  • Abstract Number: PB1735

    Differential Regulation of the Platelet GPIb-IX Complex by Anti-GPIbβ Antibodies

    M.E. Quach1, W. Chen1, Y. Wang1, H. Deckmyn2, F. Lanza3, B. Nieswandt4, R. Li1

  • Abstract Number: PB0857

    Differential Systemic Transcriptional Responses to Induced Joint Bleeding in Wild-type and Factor VIII-deficient Mice

    E. Cooke, C. Nasamran, K. Fisch, A. von Drygalski

  • Abstract Number: PB2376

    Dilemma in Initiating Thromboprophylaxis in Critically Ill Patients

    P. Lasut, V. Irawan, R. Adiwinata, C. Kawengian, C. Hendratta, L. Rotty, H. Haroen

  • Abstract Number: PB0738

    Dipicolinic Acid Produced by Fermentation (Bacillus subtilis natto)

    H. Sumi1, T. Mitsuo2, H. Inoue3

  • Abstract Number: PB/CO01

    Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients

    S. Kalayoglu Besisik, M. Ozbalak, Y.B. Tor, A. Alibeyoglu, M. Kose, N. Şenkal, A. Cagatay, M. Erelel, A. Gul, F. Esen, S. Umman, U. Isoglu Alkoclar, T. Tukek

  • Abstract Number: PB2398

    Direct Oral anti-Xa Inhibitors for Treatment of Venous Thromboembolism after Gastrectomy: Report on 3 Cases

    L. Eischer1, S. Eichinger1, P. Quehenberger2, P.A. Kylre1

  • Abstract Number: PB2492

    Direct Oral Anticoagulants and Antiepileptic Drugs: Is There Room for Concurrent Treatment?

    S. Barbar1, M. Simonetto2, E. De Bon3, L. Scarano3, G. Caneve2, N. Simioni3

  • Abstract Number: PB2414

    Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Cerebral Vein Thrombosis

    M. Capecchi1,2, M. Abbattista1, F. Gianniello1, A. Artoni1, P. Bucciarelli1, F. Peyvandi1,3,4, I. Martinelli1

  • Abstract Number: PB1128

    Direct Oral Anticoagulants Bleeding Events in Patients with Atrial Fibrillation Vs Venous Thromboembolism Admitted to an Emergency Department: Real-Life Study

    F. Moustafa1,2, T. Fleuchot1, D. Teissandier1, J. Schmidt1,2

  • Abstract Number: PB2465

    Direct Oral Anticoagulants in Comparison with Vitamin K Antagonists and Antiplatelet Agents on Timing and Outcomes in Hip Fracture Surgery Patients Older than 75: The ORTHO-GER-DOAC Study

    B. Cosmi1, E. Martini2, S. Sandri3, M.L. Lunardelli2, F.L. Gorgoglione4, A. De Laurenzo5, E. Grandone5

  • Abstract Number: PB2161

    Direct Oral Anticoagulants in Patients with Hematological Malignancies

    A. Serrao1, L. Fiori2, C. Santoro3, M. Breccia2, E. Baldacci3, M.L. De Luca2, G. De Luca2, F. Barone2, A. Chistolini3

  • Abstract Number: PB2467

    Direct Oral Anticoagulants in Patients with Severe Familial Thrombophilia

    D. Tormene, C. Simion, M. Marobin, G. Turatti, A. Pontarin, E. Campello, P. Simioni

  • Abstract Number: PB1926

    Direct Oral Anticoagulants versus Vitamin K Antagonists in Antiphospholipid Syndrome: A Meta-analysis

    A. Iriarte Fuster1, P. Cerdà Serra1, J.M. Mora Luján1, J. Cortés Hernandez2, M. Llaberia Torrelles1, K. Lopez Aldabe1, X. Corbella Virós1,3, C. Becattini4, A. Riera Mestre1,5

  • Abstract Number: PB2484

    Direct Oral Anticoagulants vs. Warfarin for the Treatment of Venous Thromboembolism in Patients with Thrombophilia. A Single Center Experience

    S. Basaria, M. Elsebaie, J. Li, M. Gaddh

  • Abstract Number: PB1666

    Direct Temporal Labelling of Platelets in vivo Allows Monitoring and Examination of Newly Formed and Aged Platelets to Reveal Changes in Receptor Expression Levels and Loss of Functional Ability

    P. Armstrong1, A. Joshi2, M. Crescente1, M. Mayr2, T. Warner1

  • Abstract Number: PB/CO06

    Disantangling the Mechanisms behind the Thrombotic Complications of COVID-19 Patients: Insights into Platelet and Endothelial Activation

    P. Canzano1, M. Brambilla1, E. Tortorici2, N. Cosentino1, B. Porro1, M. Pengo2, A. Bonomi1, F. Veglia1, G. Parati2, V. Cavalca1, E. Omodeosalè1, E. Tremoli1, M. Camera1,3

  • Abstract Number: PB1402

    Discontinuation of Chronic Low Dose Acetylsalicylic Acid Therapy Upon Intensive Care Medicine Department Admission Appears to Increase Mortality

    F. Martins Pereira1, S. Abreu2, P. Mergulhão3,4, J.A. Paiva4,5,6

  • Abstract Number: PB0208

    Discordance Between the Neutralization Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban in the Clotting Assays and Anti-Xa Measurements

    F. Siddiqui1, A. Tafur2, D. Hoppensteadt1, E. Bontekoe1, W. Jeske1, B. Lewis1, J. Fareed1

  • Abstract Number: PB0835

    Discrepancies between FVIII Assays in Routine Diagnosis and Treatment Monitoring of Haemophilia A

    C. Fauconnier, M.-A. van Dievoet, C. Lambert, J.-P. Defour, S. Eeckhoudt, C. Hermans

  • Abstract Number: PB0570

    Discrepant Interpretation of HIT Screening Results on the Same Sample – Data from a UK NEQAS for Blood Coagulation Exercise

    I. Jennings, S. Kitchen, D. Kitchen, S. Munroe-Peart, A. Lowe, L. Brown, I. Walker

  • Abstract Number: PB0526

    Discrimination between Acquired Hemophilia A and Lupus Anticoagulant Using Rotational Thromboelastometry (ROTEM)

    Y. Chikasawa1, K. Amano1,2, R. Miyashita1, T. Yamaguchi1, Y. Kamikubo1, A. Ichiki1, M. Bingo1, R. Sekiya1, T. Muramatsu1, M. Yotsumoto1, M. Kaneko1, K. Shinozawa2, T. Hagiwara1, H. Inaba1, E. Kinai1

  • Abstract Number: PB2547

    Disorders in the Fibrinolytic System as a Possible Factor in the Failure of Assisted Reproductive Technologies

    S. Safiullina1,2, T. Vuimo3, Y. Kotova3, N. Ilizarova4

  • Abstract Number: PB1002

    Dissecting the Paradox of “Severe” Hemophilia A (Clotting Factor VIII < 1%) with a Mild Clinical Phenotype in the Era of Prophylaxis

    O.S. Bentur, B.S. Coller

  • Abstract Number: PB0644

    Distinguishing Patients Presenting Prolonged Activated Partial Thromboplastin Time with and without Bleeding Diathesis by Comparison of Immediate and post Incubation Mixing Test

    Y. Liu1, W. Wu2, X. Wang2

  • Abstract Number: PB1028

    Distribution of Hemophilia A and B within the INSIGHT Consortium

    A.-F. Zwagemaker1, F.R. Kloosterman1, J. Astermark2, M. Carcao3, N. O'Connell4, G. Castaman5, S. Haya6, D.P. Hart7, C. Hermans8, S. Jackson9, R. Klamroth10, R. Lassila11, R. Liesner12, C. Male13, S. McRae14, K. Peerlinck15, H. Platokouki16, E. Santagostino17, C. Santoro18, K. Fijnvandraat1,19

  • Abstract Number: PB0619

    DOAC Intra-individual Variability in Patients with Non Valvular Atrial Fibrillation

    O. Paoletti1, C. Dellanoce1, C. Legnani2, V. Cancelli1, R. Morandini1, M. Tala1, E. Cancellieri1, S. Zambelli1, M.C. Beati1, M. Stramezzi1, E. Spotti1, V. Castellani1, S. Lambiase1, S. Testa1

  • Abstract Number: PB1719

    DOAC Pharmacogenomics: Personalized Therapeutics to Avoid Bleeding and Thrombotic Complications

    C. Schekel1, F. Shamoun2, M. Abdelmalek2, J. Wang2, M. Girardo2, Y. Kusne2

  • Abstract Number: PB0632

    Doac-Remove™ Can Neutralize the Effect of Direct Oral Anticoagulants on Lupus Anticoagulant Assay: A Single-centre Experience

    D. Velasco-Rodríguez, R. Vidal Laso, M. López Pérez, S. Martín Herrero, E. Jíménez Barral, A. García-Raso, R. de la Plaza, L.F. López Romero, D. Mínguez, M.Á. Bueno, P. Llamas Sillero

  • Abstract Number: PB2479

    DOACs in Real Clinical Practice

    M. Hulikova1,2, J. Hulikova2

  • Abstract Number: PB2181

    Does blood Group Predicts Thrombosis Risk? A Pilot Study Assessing Thrombin Generation

    M. Marcos Jubilar1, D. Terrasa2, M.L. Palacios1, V. Riego1, L.E. Tamariz1, R. Lecumberri1, J.A. Páramo1,3,4

  • Abstract Number: PB0551

    Does Normal Diluted Russell Viper Venom Time Test Result Can Exclude Concentrations of Direct Oral Anticoagulants below 30 ng/mL?

    S. Margetić1, I. Ćelap2, R. Mihić2, S. Supraha Goreta3

  • Abstract Number: PB1910

    Does the von Willebrand Factor: ADAMTS-13 Axis Differ between Antiphospholipid Syndrome and Systemic Lupus Erythematosus?

    M.N. Dang1, R. Thiagarajan1, I. Mackie2, H. Cohen2,3, D. Isenberg4,5, T. McKinnon1, M. Efthymiou2

  • Abstract Number: PB0938

    Does Variation between Label and Actual Potency of Factor VIII Concentrate Vials Affect Results of Pharmacokinetic (PK)-Guided Dosing of Replacement Therapy in Hemophilia A?

    M.H.J. Goedhart1, L.H. Bukkems2, I. van Moort1, C.C. Spence1, S.C. Gouw3, R.A.A. Mathôt2, M.H. Cnossen1, for the OPTI-CLOT Study Group

  • Abstract Number: PB0751

    Down-regulation of Plasminogen Activator Inhibitor-1 (PAI-1) by in vivo Thrombin Generation and Subsequent Formation of Activated Protein C (APC) in Carriers of the Factor V Leiden (FVL) and Prothrombin 20210G>A Mutation (PTM)

    S. Reda, F.I. Winterhagen, C. Berens, J. Müller, J. Oldenburg, B. Pötzsch, H. Rühl

  • Abstract Number: PB0745

    Downregulation of the Procarboxypeptidase U (proCPU, TAFI, proCPB2) System in ApoE-/-Fbn1C1039G+/- Mice Is a Non-Lipid Related Pleiotropic Effect of Statin Therapy

    K. Claesen1, K. Hermans1, L. Roth2, J.C. Mertens1, I. De Meester1, G.R.Y. De Meyer2, D. Hendriks1

  • Abstract Number: PB0651

    DP-Filter, a Medical Device to Remove Edoxaban and Edoxaban-M4 from Plasma of Patients Taking Edoxaban

    J. Favresse1, C. Bouvy2, R. Sirriez1, P. Hainaut3, H. Yildiz3, A.-S. Delvigne2, M. Hardy4, F. Mullier5, J.-M. Dogné1, J. Douxfils1,2

  • Abstract Number: PB0164

    Drug Interactions in Edoxaban Treated Patients: A Pilot Study Revealing the Changes of the Metabolite to Parent Ratio and its Potential Clinical Importance

    R. Siriez1, J.-M. Dogné1,2, J. Douxfils1,3, M. Hardy4,5, J. Laloy2,6, F. Mullier4, H. Yildiz7, P. Hainaut7

  • Abstract Number: PB2459

    Drug-Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: A Systematic Review

    M. Bellesini1,2, M. Bianchin3, C. Corradi4, M.P. Donadini1,2, E. Raschi5, A. Squizzato4,6

  • Abstract Number: PB1478

    Dual Antiplatelet Therapy in One Patient with a Immune GPVI Deficiency

    M. Jandrot-Perrus1, S. Loyau1, D. Faille1,2, P. Gautier3, E. Gardiner4, P. Nurden5, N. Ajzenberg1,2

  • Abstract Number: PB0933

    Dynamic Changes in Peripheral Blood Transcriptome Profiles May Predict Inhibitor Formation in Previously Untreated Patients with Severe Hemophilia A

    P. Batty1,2, D. Watson1, E. Wozniak1, E. Savage1, C.A. Mein1, M.R. Barnes1, D.P. Hart1,2

  • Abstract Number: PB2260

    Dynamic Upper Limb Ultrasound in Idiopathic Upper Extremity Deep Vein Thrombosis

    H.L.A. Yuen1,2, S. Chunilal1,2

  • Abstract Number: PB2155

    Dynamics of ADAMTS13 and vWF Activity Change in Ovarian Cancer Patients

    A. Vorobev1, V. Bitsadze1, J. Khizroeva2, A. Makatsariya2, A. Solopova2, M. Meng2

  • Abstract Number: PB1753

    Dysfunctional CLEC-2- and GPVI-mediated Signaling in Syk Y342F Knock-in Mouse Platelets

    J. Kostyak, B. Mauri, C. Dangelmaier, A. Patel, H. Reddy, S. Kunapuli

  • Abstract Number: PB1602

    Dysfunctional RBM8A/Y14 Does Not Impair Megakaryopoiesis but Terminal Thrombopoiesis in Thrombocytopenia Absent Radii (TAR) Syndrome

    G. Manukjan1, C. Brähler1, M. Becker1, H. Bösing1, C.K. Kwok2, F. Edenhofer2, C. Ghevaert3, D. French4, H. Schulze1

  • Abstract Number: PB0461

    Dyslipidaemia Associated with Increase of Thrombin Generation in Renal Transplant Recipients

    S. Martins, L. Alves, M.D.G. Carvalho, L. Dusse, P. Alpoim, A.P. Mota

  • Abstract Number: PB1480

    Dysregulation of Platelet Serotonin and Platelet 14-3-3-Related Biomarkers in Sudden Infant Death Syndrome

    A.L. Frelinger III1,2, R.L. Haynes2,3, R.D. Goldstein2,4, M.A. Berny-Lang1, A.J. Gerrits1, M. Riehs3, E.A. Haas5, B. Paunovic6, G.L. Milne7, L.A. Sleeper2,8, H.C. Kinney2,3, A.D. Michelson1,2

Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.